Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug 17:6:109.
doi: 10.3389/fbioe.2018.00109. eCollection 2018.

Polydopamine Nanomaterials: Recent Advances in Synthesis Methods and Applications

Affiliations
Review

Polydopamine Nanomaterials: Recent Advances in Synthesis Methods and Applications

Vincent Ball. Front Bioeng Biotechnol. .

Abstract

Polydopamine (PDA), the final oxidation product of dopamine or other catecholamines, attracted much attention as versatile coatings that can be used to cover the surface of almost all materials with a conformal layer of adjustable thickness ranging from a few to about 100 nm. These PDA layers can be subsequently modified with molecules carrying nucleophilic groups or with metallic nanoparticles from solutions containing metallic cations. However, during the deposition of PDA film on the surfaces, the reaction products that are simultaneously obtained from the oxidation of catecholamines in solution precipitate. Hence, some recent effort has been devoted to produce PDA in the form of nanoparticles. The aim of this short review is to give a comprehensive description of the synthesis methods yielding of PDA nanoparticles in the absence or in the presence of templating agents (polymers, polyelectrolytes, surfactants, proteins, and even some small organic molecules). We will also describe the use of thin PDA layers to coat already synthesized nanoparticles or nanotubes. Finally, several first applications of the obtained PDA nanoparticles will be described.

Keywords: nanotubes; polydopamine; polydopamine nanoparticles; polyelectrolytes; proteins; surfactants.

PubMed Disclaimer

Figures

Scheme 1
Scheme 1
Characteristic structure of catecholamines: dopamine, norepinephrine, and L-DOPA (from left to right).
Figure 1
Figure 1
(A) AFM surface topographies of PDA-NaIO4-20mM films on silicon wafers as a function of the reaction time. (B) Underwater contact angles of CHCl3 (left) and water contact angles (right) for PDA-O2-2 h (left) and PDA-NaIO4-20 mM-2 h (right) films. (C) Adsorption of BSA-FITC on PDA-O2-2 h (left) and PDA-NaIO4-20 mM−2 h (right). Reproduced from Ponzio et al. (2016) with authorization.
Scheme 2
Scheme 2
Chemical pathways leading to eumelanin (left column) and pheomelanin (right column) in living organisms. The first enzymatically catalyzed step is omitted in the synthesis of synthetic melanins. Reproduced from Ito (1989), with authorization.
Figure 2
Figure 2
Hydrodynamic radius (left hand vertical scale, formula image) and fractal dimension (right hand vertical scale, formula image) of eumelanin grains obtained at the end of the reaction kinetics from L-DOPA solutions, as function of the pH. Reproduced from Bridelli (1998) with authorization.
Figure 3
Figure 3
Hydrodynamic diameter (A) and zeta potential (B) of PDA particles obtained after 24 h of dopamine oxidation (2 mg.mL−1 in the presence of 50 mM Tris buffer at pH = 8.5) as a function of the PAH concentration in the reaction medium. The error bars correspond to one standard deviation on the mean (n = 10 measurements). The black dashed line in (B) corresponds to the zero value of the zeta potential and is aimed to guide the eye. The vertical red dashed line corresponds to the PAH concentration (0.7 mg.mL−1) above which the PDA particles remain stable, without phase separation, even after prolonged storage. The inset in (A) corresponds to a picture of the PDA containing solutions taken 7 days after the completion of the oxygenation of the dopamine solutions in the presence or in the absence of PAH as indicated with blue arrows. (C) 13C CP-MAS Spectra of the PAH-only sample (red curve), PAH-PDA (blue curve), and pristine PDA (green curve). The PAH concentration was 2 mg.mL−1 in the synthesis batch as well as in the reference PAH solution. Data have been taken from Mateescu et al. (2016) with authorization.
Figure 4
Figure 4
(A) Absorbance at λ = 350 nm vs. time for dopamine solutions placed in oxidizing conditions (in the presence of O2 from the air and at pH = 8.5, 50 mM Tris buffer) in the absence of HSA (formula image) and in the presence of HAS at various concentrations: 0.2 mg.mL−1 (formula image), 1 mg.mL−1 (formula image), and 2 mg.mL−1 (formula image). The horizontal dashed line corresponds to the saturation absorption at the end of the oxidation kinetics of dopamine. (B) Hydrodynamic diameter of PDA particles synthesized for 24 h from a 2 mg.mL−1 dopamine solution (50 mM Tris buffer at pH = 8.5) in the presence of HSA at different concentrations (formula image). Hydrodynamic diameter of PDA particles prepared in the same conditions as previously described and stored in a closed bottle (without refreshed air) for 3 months before characterization by dynamic light scattering (formula image). Reproduced from Chassepot and Ball (2014) with authorization.
Figure 5
Figure 5
(A) Evolution of the hydrodynamic diameter of PDA aggregates as a function of the surfactant concentration in the case of SDS (formula image), HTAB (formula image), and Triton X-100 (formula image). The dopamine concentration was 2 mg.mL−1 in the presence of 50 mM Tris buffer at pH = 8.5 in all experiments. The long-dashed lines in the upper part of the figure correspond to the size of the PDA prepared in the absence of surfactant, whereas the short-dashed lines in the lower part of the figure corresponds to the size of the surfactant micelles [measured in the case of SDS (formula image) and HTAB (formula image)]. (B) Relative deposition of PDA films as calculated by dividing the thickness of the PDA films, obtained on silicon in the presence of a surfactant, by the film thickness obtained in the absence of a surfactant. The film thickness was obtained by means of single wavelength ellipsometry fixing the complex refractive index of PDA to 1.73 ± 0.02i at λ = 632.8 nm. The deposition of PDA on silicon was investigated in the presence of different concentrations of SDS (___formula image___), HTAB (formula image), sodium octylsulfate (formula image), and Triton X-100 (formula image). The error bars are calculated from the standard errors on the film thickness produced both in the absence and presence of surfactants. The long-dashed line has the same significance as in (A). Reproduced from Ponzio et al. (2014a) with authorization.
Figure 6
Figure 6
(A) Thickness of (PDADMAC-PDA)n multilayer films deposited on silicon slides as measured by single wavelength ellipsometry (circles) and linear regressions to the data (lines). The error bars represent one standard deviation over 5 measurements taken on the same sample. (formula image), Films deposited immediately after the end of the 24 h dopamine oxidation (2 mg.mL−1 at pH = 8.5), (formula image), film deposited after 3.5 days of aging of the PDA suspension. Inset: Slope of the thickness vs. the number of layer pairs as a function of the aging time of the PDA suspension before deposition of the (PDADMAC-PDA)n film. (B) UV-visible spectra of the (PDADMAC-PDA)n films for n = 2 (black solid line), n = 4 (black long-dashed line), n = 6 (red solid line), and n = 8 (blue solid line). For these experiments, the PDA containing suspension was aged for 24 h before the film deposition. The inset displays the absorbance at λ = 589 nm as a function of the number of deposited layer pairs. The straight line and the dashed lines correspond to a linear regression to the data and to the limits of the 95% confidence interval, respectively. (C) AFM topographies of a (PDADMAC-PDA)10 film prepared using a PDA containing solution aged for 3 days before film deposition. Reproduced from Bernsmann et al. (2010) with authorization.

References

    1. Amin D. R., Sugnaux C., Aaron Lau K. H., Messersmith P. B. (2017). Size control and fluorescence labelling of polydopamine melanin-mimetic nanoparticles for intracellular imaging. Biomimetics 2, 17–36. 10.3390/biomimetics2030017 - DOI - PMC - PubMed
    1. Arzillo M., Mangiapia G., Pezzella A., Heenan R. K., Radulescu A., Paduano L., et al. . (2012). Eumelanin buildup on the nanoscale: aggregate growth/assembly and visible absorption development in biomimetic 5,6-dihydroxyindole polymerization. Biomacromolecules 13, 2379–2390. 10.1021/bm3006159 - DOI - PubMed
    1. Ball V. (2010). Impedance spectroscopy and zeta potential titration of melanin films produced by oxidation of dopamine. Colloids Surfaces A. Physicochem. Eng. Asp. 363, 92–97. 10.1016/j.colsurfa.2010.04.020 - DOI
    1. Bernsmann F., Ersen O., Voegel J.-C., Jan E., Kotov N. A., Ball V. (2010). Melanin-containing films: growth from dopamine solutions versus layer-by-layer deposition. ChemPhysChem 11, 3299–3305. 10.1002/cphc.201000384 - DOI - PubMed
    1. Bernsmann F., Voegel J.-C., Ball V. (2011). Different synthesis methods allow to tune the permeability and permselectivity of dopamine-melanin films to electrochemical probes. Electrochimica Acta 56, 3914–3919. 10.1016/j.electacta.2011.02.028 - DOI